Tci Wealth Advisors, Inc. Adverum Biotechnologies, Inc. Transaction History

Tci Wealth Advisors, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 29, 2021	SELL	$2.08 - $3.6 $1,358 - $2,350	-653 Closed	0 $0
Q2 2021 Aug 02, 2021	BUY	$3.36 - $10.56 $1,616 - $5,079	481 Added 279.65%	653 $2,000
Q1 2021 Apr 29, 2021	BUY	$9.26 - $14.36 $1,592 - $2,469	172 New	172 $2,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.